Sort
64,565 grants matching “drug discovery”
Mutagenic And Toxic Effects Of Base Analogs
$551,624Roeland Schaaper · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Candidate Medications for Cannabis Addiction: FAAH Inhibitors
$551,624Jack Bergman · Mclean Hospital · R01 · FY2011 · DA
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS
$551,619Yana Yunusova · Sunnybrook Research Institute · R01 · FY2020 · DC
NOVEL BIOMARKERS FOR AROMATASE INHIBITOR THERAPY
$551,616Matthew J Ellis · Washington University · R01 · FY2009 · CA
Software Platform for Analyzing Alzheimer's and Parkinson's fMRI Connectomes
$551,598William D Shannon · William D Shannon Consulting, Llc · R44 · FY2016 · AG
Live-Cell Assays for Lysosomal Enzyme Activity
$551,594John J Naleway · Marker Gene Technologies · R44 · FY2013 · NS
Development of antibacterial agents and materials
$551,535Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
NOTCH3 Signaling in Pulmonary Hypertension
$551,527Patricia A Thistlethwaite · University Of California, San Diego · R01 · FY2014 · HL
Tools for rapid and accurate structure elucidation of natural products
$551,472William H Gerwick · University Of California, San Diego · R01 · FY2017 · GM
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno
$551,410David Alan Mead · Lucigen Corporation · R44 · FY2014 · AI
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
$551,408Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2025 · AI
Development of a fluorescence ABCG2 liposomal multidrug transporter assay
$551,369Donald Lee Melchior · Tfc Biosciences, Inc. · R44 · FY2017 · GM
Expression Pattern Screening for Drug Discovery
$551,315Siddco, Inc. · R44 · FY2001 · CA
Biomolecular Recognition and Binding Mechanisms
$551,300Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Discovery of functionally selective Alzheimer's disease therapeutics
$551,284Robert R Luedtke · University Of North Texas Hlth Sci Ctr · R01 · FY2018 · AG
Development of antibacterial agents and materials
$551,277Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
$551,250Rama K Mallampalli · Ohio State University · R33 · FY2022 · HL
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$551,244Amy Kristine Bei · Yale University · R01 · FY2025 · AI
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
$551,047Rama K Mallampalli · Ohio State University · R33 · FY2023 · HL
Computational- and experimental- driven discovery of splicing regulation and circRNA function
$550,950Julia Salzman · Stanford University · R35 · FY2022 · GM
Heteroresistance Interdisciplinary Research Unit (Project 2)
$550,933David S Weiss · Emory University · U19 · FY2023 · AI
High-Throughput Screening for Dab2 Inhibitors as Stabilizers of CFTR
$550,884Dean R Madden · Dartmouth College · R01 · FY2016 · DK
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)
$550,881Stephen W Byers · Georgetown University · R01 · FY2013 · CA
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
$550,823Sudha K Shenoy · Duke University · R01 · FY2024 · HL
Clonal Reconstruction and Targeting of the Correa Sequence
$550,822Frank D. McKeon · University Of Houston · R01 · FY2023 · CA